Used in pharmaceutical research as a key intermediate in the synthesis of centrally acting agents targeting neurological disorders. Shows potential in the development of dopamine and serotonin receptor modulators, particularly for treating depression, anxiety, and addiction. Its structural features allow for high affinity binding to specific neural receptors, making it valuable in optimizing brain-penetrant therapeutics. Also explored in the design of selective inhibitors for enzymes involved in neurotransmitter regulation.